Aspirin cuts colon cancer risk
It has been well-established that aspirin is good for the heart, and now research from Massachusetts General Hospital provides evidence that the same pill could also help reduce the risk of colon cancer. The study found that risk of colon cancer can be lowered by as much as 27 percent if a person takes aspirin at least twice a week, as compared to those who took fewer doses or no aspirin at all. However, aspirin was found to have benefits only for colon cancer strains that did not have a BRAF mutation, which account for 10 to 15 percent of cases.
In a study of 127,000 people followed from the 1980s to today, the researchers documented 1,226 cases of colon cancer. They found that colon cancer occurred at a rate of 40.2 cases per 100,000 people among those who did not take aspirin, but was reduced to 30.5 cases per 100,000 among those who did regularly take aspirin. Those who took six to 12 doses of aspirin weekly were 30 percent less likely to develop non-BRAF mutated cancer than those who took no aspirin. For BRAF mutation colon cancers, there was no difference in occurrence between those who took aspirin and those who did not.
Despite its potential benefits, aspirin is not recommended as a cancer prevention technique, as there are risks of gastrointestinal bleeding and negative effects. You should always consult with a doctor before beginning an aspirin regimen.